Skip to main content
SpringerLink
Log in

The ‘antiphospholipid syndrome’ and the ‘lupus anticoagulant’

  • Nephrology Review
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

In recent years an association has been described between, on the one hand, an in vitro prolongation of phospholipid-dependent coagulation tests (the ‘lupus anticoagulant’) or the demonstration of antiphospholipid antibodies and, on the other, clinical events, particularly recurrent thrombosis (usually venous but sometimes arterial), thrombocytopenia, and also recurrent mid-term fetal loss. Other less well-documented associations with haemolytic anaemia, livedo reticularis, strokes and other neurological syndromes have been suggested. The antibodies are present temporarily in many infections, are usually of IgM isotype and thrombosis does not occur. However, they are persistently present and mainly of IgG isotype in a number of auto-immune disorders associated with thrombosis, in particular systemic lupus erythematosus, in which 50% of patients will show antibody of one isotype or another. The strongest association is with antinuclear factor-negative lupus and ‘lupus-like’ disorders in which a full diagnosis of classical lupus cannot be made. The clotting test abnormality and antiphospholipid antibodies may be found also in otherwise normal individuals suffering thrombosis or fetal loss — the so-called primary antiphospholipid syndrome. These data raise important questions for management, but many details are controversial despite a decade's work; this review examines the present position and outlines some of the difficulties, particularly from the point of view of nephrology and paediatrics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wasserman A, Neisser A, Bruck C (1906) Eine serologische Reaktion bei Syphilis. Dtsch Med Wochenschr 32:745–746

    Google Scholar 

  2. Pangborn MC (1941) A new serologically active phospholipid from beef heart. Proc Soc Exp Biol Med 48:484–486

    Google Scholar 

  3. Gennerich W (1921) Über die Ätiologie des lupus erythematodes. Arch Syphil Dermatol 135:184–207

    Google Scholar 

  4. Moore JE, Lutz WB (1955) The natural history of lupus erythematosus: an approach to its study through chronic biologic false positive reactors. J Chron Dis 1:297–316

    Google Scholar 

  5. Conley CC, Hartmann RC (1952) A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 31:621–622

    Google Scholar 

  6. Feinstein DI, Rapaport SI (1972) Acquired inhibitors of blood coagulation. Prog Hemost Thromb 1:75–95

    Google Scholar 

  7. Bowie WEJ, Thompson JH, Pascuzzi CA, Owen CA (1963) Thrombosis in systemic lupus erythematosus. J Clin Invest 62:416–430

    Google Scholar 

  8. Lechner K (1969) A new type of coagulation inhibitor. Thromb Diath Haemorrh 21:482–499

    Google Scholar 

  9. Schleider MA, Nachman RL, Jaffe EA, Coleman M (1976) A clinical study of the lupus anticoagulant. Blood 48:499–509

    Google Scholar 

  10. Johanssen EA, Lassus A (1955) The occurrence of circulating anticoagulants in patients with syphilis and biologic false positive antilipoidal antibodies. Blood 6:105–108

    Google Scholar 

  11. Laurell A-B, Nilsson IM (1957) Hypergammaglobulinemia, circulating anticoagulant and biologic false positive Wasserman reactions. J Lab Clin Med 49:694–707

    Google Scholar 

  12. Thiagarajan P, Shapiro SS, Marco L de (1980) Monoclonal immunoglobulin M coagulation inhibitor with phospholipid specificity-mechanism of a lupus anticoagulant. J Clin Invest 66:397–405

    Google Scholar 

  13. Shapiro SS, Thiagarajan P (1982) Lupus anticoagulants. Prog Hemost Thromb 6:263–285

    Google Scholar 

  14. Mueh JR, Herbst KD, Rapaport SI (1980) Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 92:156–159

    Google Scholar 

  15. Williams H, Laurent R, Gibson T (1980) The lupus coagulation inhibitor and venous thrombosis: report of four cases. Clin Lab Haematol 2:139–144

    Google Scholar 

  16. Boey ML, Colaco CB, Gharavi AE, Elkon KB, Loizou S, Hughes GRV (1983) Thrombosis in SLE: striking association with the presence of circulating ‘lupus anticoagulant’. Br Med J 287:1021–1023

    Google Scholar 

  17. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, Hughes GRV (1983) Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet II:1211–1214

    Google Scholar 

  18. Nilsson IM, Astedt B, Hedner V, Berezin D (1975) Intrauterine death and circulating anticoagulant (‘antithromboplastin’). Acta Med Scand 197:153–159

    Google Scholar 

  19. Firkin BG, Howard MA, Radford N (1980) Possible relationship between lupus inhibitor and recurrent abortions in young women. Lancet II:366

    Google Scholar 

  20. Soulier J-P, Boffa M-C (1980) Avortement a repetition, thrombose et anticaogulant circulant antithromboplastine. Nouv Presse Med 9: 859–864

    Google Scholar 

  21. Carreras LO, Defreyn G, Machin SJ, Vermylen J, Deman R, Spitz B, Assche A van (1981) Arterial thrombosis, intrauterine death and lupus anticoagulant: detection of an inhibitor of prostacyclin formation. Lancet I:244–246

    Google Scholar 

  22. Lockshin MD, Druzin ML, Goei S, Qamar T, Magid MS, Jovanovic L, Ferenc M (1985) Antibody to cardiolipin as a predictor of fetal distress or death. N Engl J Med 313:152–156

    Google Scholar 

  23. Derue GJ, Englert HJ, Harris EN, Hughes GRV (1985) Fetal loss in systemic lupus: association with anticardiolipin antibodies. J Obstet Gynaecol 5:207–209

    Google Scholar 

  24. Hughes GRV (1983) Thrombosis, abortion, cerebral disease and the lupus anticoagulant. Br Med J 287:1088–1089

    Google Scholar 

  25. Perico N, Pusinieri F, Remuzzi G (1984) The lupus anticoagulant. Proc Soc Exp Biol Med 176:337–341

    Google Scholar 

  26. Editorial (1984) Lupus anticoagulant. Lancet I:1157–1158

  27. Feinstein DI (1985) Lupus anticoagulant, thrombosis and fetal loss. N Engl J Med 313:1348–1350

    Google Scholar 

  28. Editorial (1985) Anticardiolipin antibodies: a risk factor for thrombosis. Lancet I:912–913

  29. Harris EN, Gharavi AE, Hughes GRV (1985) Antiphospholipid antibodies. Clin Rheum Dis 11:591–609

    Google Scholar 

  30. Hughes GRV, Harris EN, Gharavi AE (1986) The anticardiolipin syndrome. J Rheumatol 13:486–489

    Google Scholar 

  31. Harris EN (1987) Syndrome of the black swan. Br J Rheumatol 26: 324–326

    Google Scholar 

  32. Colaco CB, Elkon KB (1985) The lupus anticoagulant: a disease marker in anti nuclear antibody negative lupus that is cross reactive with autoantibodies to double stranded DNA. Arthritis Rheum 28: 68–74

    Google Scholar 

  33. Hughes GR, Asherson RA (1985) Atypical lupus with special reference to ANA negative lupus and lupus subsets. Adv Nephrol 14: 333–346

    Google Scholar 

  34. Meyer O, Piette J-C, Bourgeois P, Fallas P, Bletry O, Jungers P, Kahn M-F, Godeau P, Ryckwaert A (1987) Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE. J Rheumatol 14:502–506

    Google Scholar 

  35. Frampton G, Cameron JS, Hartley RB (1987) Glomerular thrombi in lupus nephritis: an association with the presence of IgG anti-cardiolipin antibody (abstract). Nephrol Dial Transplant 2:424

    Google Scholar 

  36. Derksen RHMW, Bouma BN, Kater L (1987) The prevalence and clinical associations of the lupus anticoagulant in systemic lupus erythematosus. Scand J Rheumatol 16:185–192

    Google Scholar 

  37. Sturfelt G, Nived O, Norberg R, Thorstensson R, Krook K (1987) Anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 30:382–388

    Google Scholar 

  38. Petri M, Rheinschmidt M, Whiting-O'Keefe Q, Hellmann D, Corash L (1987) The frequency of lupus anticoagulant in systemic lupus erythematosus: a study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin level. Ann Intern Med 106:524–531

    Google Scholar 

  39. Derksen RHMW, Haselaar P, Blokzijl L, Gmelig Meyling FHJ, Groot PG de (1988) Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients. Ann Rheum Dis 48:364–371

    Google Scholar 

  40. Hazeltine M, Rauch J, Danoff D (1988) Antiphospholipid antibodies in systemic lupus erythematosus: evidence of an association with positive Coombs' and hypocomplementemia. J Rheumatol 15: 80–86

    Google Scholar 

  41. Weidmann CE, Wallace DJ, Peter JB, Knight PJ, Bear MB, Klinenberg JR (1988) Studies of IgG IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus. J Rheumatol 15: 74–79

    Google Scholar 

  42. Kalunian KC, Peter JB, Middlekauff HR, Sayre J, Ando DG, Mangotich M, Hahn BH (1988) Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med 85:602–608

    Google Scholar 

  43. Cronin ME, Biswas RM, Staeton C van der, Fliesher TA, Klippel JH (1988) IgG and IgM anticardiolipin antibodies in patients with lupus with anticardiolipin antibody associated syndromes. J Rheumatol 15: 795–798

    Google Scholar 

  44. Alarcon-Segovia D, Deleze' M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabieides J, Fernandez L, Ponce de Leon S (1989) Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective study of 500 consecutive patients. Medicine 68:353–365

    Google Scholar 

  45. Shergy WJ, Kredich DW, Pisetsky DS (1987) The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus. J Rheumatol 15:1389–1394

    Google Scholar 

  46. Montes de Oca M, Babron MC, Levy M (1990) Thrombosis and lupus anticoagulant in children with systemic lupus erythematosus. A French collaborative study (abstract). Clin Exp Rheumatol 8:216

    Google Scholar 

  47. Caporali R, Ravelli A, DeGennaro F, Viola S, Gentile S, Martini A, Montecucco C (1990) Anticardiolipin antibodies in childhood (abstract). Clin Exp Rheumatol 8:224

    Google Scholar 

  48. Watson RM, Lane AT, Barnett NK, Bias WB, Arnett FC, Provost TT (1984) Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine 63: 362–378

    Google Scholar 

  49. Katayama I, Kondo S, Kanawa S, Nishioka K, Nishiyama S (1989) Neonatal lupus erythematosus with a high anticardiolipin antibody titer. J Am Acad Dermatol 21:490–492

    Google Scholar 

  50. Petri M, Hochberg M, Hellmann D, Corash L, Goldman D (1990) The association of the lupus anticoagulant (LA) with thrombotic events (TE) in systemic lupus erythematosus (SLE): a prospective study (abstract). Clin Exp Rheumatol 8:217

    Google Scholar 

  51. Frampton G, Hicks JA, Cameron JS (1990) Isotype specific antiphospholipid antibody and their clinical correlates in lupus and lupus like nephritis (abstract). Clin Exp Rheumatol 8:213

    Google Scholar 

  52. Petri M, Golbus M, Anderson R, Whiting O'Keefe Q, Corash LM, Hellman D (1987) Antinuclear antibody, lupus anticoagulant and anticardiolipin antibody in women with idiopathic habitual abortion. Arthritis Rheum 30:601–616

    Google Scholar 

  53. Out HJ, Groot PG de, Hasselaar P, Vliet M van, Derksen RHWM (1989) Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis 48:1023–1028

    Google Scholar 

  54. Fort JG, Cowchock FS, Abruszzo JL, Smith JB (1987) Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum 30:752–760

    Google Scholar 

  55. Asherson RA, Khamashta MA, Gil A, Vazquez J-J, Chan O, Baguley E, Hughes GRV (1989) Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease and the primary antiphospholipid syndrome. Am J Med 86: 391–399

    Google Scholar 

  56. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RHWM, Machin SJ, Barquinero J, Outt HH, Harris EN, Vilardell-Torres M, Hughes GRV (1989) The ‘primary’ antiphospholipid syndrome: major clinical and serological features. Medicine 68:366–374

    Google Scholar 

  57. Coull BM, Bourdette DN, Goodnight SH Jr, Briley DP, Hart R (1987) Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. Stroke 18:1107–1112

    Google Scholar 

  58. Morton KE, Gavaghan TP, Krilis SA, Dagaard TP, Baron DW, Hickie JB, Chesterman CN (1986) Coronary artery bypass failure- an autoimmune phenomenon? Lancet II:1353–1357

    Google Scholar 

  59. Ashley S, Kruger A, McMullen KW, Darke S (1988) Prosthetic graft thrombosis associated with lupus anticoagulant. Eur J Vasc Surg 2: 57–60.

    Google Scholar 

  60. Hamsten A, Norberg R, Bjorkholm M, Faaire U de, Holm G (1986) Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet I: 113–116

    Google Scholar 

  61. Manoussakis MN, Tzioufas AG, Silis MP, Pange PJE, Goudevenos J, Moutsopoulos HM (1987) High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 69:557–565

    Google Scholar 

  62. Fields RA, Toubbeh H, Searles RP, Bankhurst AD (1989) The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies. J Rheumatol 16: 623–625

    Google Scholar 

  63. Mackworth Young C, Chan J, Harris N, Walport M, Bernstein R, Batchelor R, Hughes G, Gharavi A (1987) High incidence of anticardiolipin antibodies in relatives of patients with systemic lupus erythematosus. J Rheumatol 14:723–726

    Google Scholar 

  64. Molta CT, Meyer O, Dosquet C, Montes de Oca M, Babron MC, Danon F, Levy M (1990) French collaborative study of childhood onset systemic lupus erythematosus: anticardiolipin antibodies in probands and first degree relatives from 37 families (abstract). Clin Exp Rheumatol 8:216

    Google Scholar 

  65. Elias M, Eldor A (1984) Thromboembolism in patients with the ‘lupus’-type circulating anticoagulant. Arch Intern Med 144: 510–515

    Google Scholar 

  66. Gastineau DA, Kazmier FJ, Nichols WL, Bowie EJW (1985) Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases. Am J Hematol 19:265–275

    Google Scholar 

  67. Glueck HI, Kant KS, Weiss MA, Pollak VE, Miller MA, Coots M (1985) Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med 145: 1389–1395

    Google Scholar 

  68. Harris EN, Chan JK, Asherson RA, Aber VR, Gharavi AE, Hughes GR (1986) Thrombosis, recurrent fetal loss, and thrombocytopenia: predictive value of the anticardiolipin antibody test. Arch Intern Med 146:2153–2156

    Google Scholar 

  69. Tobelem G, Carion R, Camez A (1987) The lupus anticoagulant and its role in thrombosis. Blood Rev 1:21–24

    Google Scholar 

  70. Chu P, Pendry K, Blevher TE (1988) Detection of lupus anticoagulant in patients attending an anticoagulation clinic. Br Med J 297: 1449

    Google Scholar 

  71. Chartash EK, Lans DM, Paget SA, Qamar T, Lockshin MD (1989) Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med 86:407–412

    Google Scholar 

  72. St Clair W, Rogers JS, Crough M, Hrabowsky E (1981) Deep venous thrombosis and a circulating anticoagulant in systemic lupus erythematosus. Am J Dis Child 135:230–232

    Google Scholar 

  73. Bernstein ML, Salusinsky-Sternbach M, Bellfleur M, Esseltine DW (1984) Thrombotic and hemorrhagic complications in children with the lupus anticoagulant. Am J Dis Child 138:1132–1135

    Google Scholar 

  74. Kleinknecht D, Bobrie G, Meyer O, Noel L-H, Callard P, Ramdane M (1989) Recurrent thrombosis and renal vascular disease in patients with a lupus anticoagulant. Nephrol Dial Transplant 4:854–858

    Google Scholar 

  75. Liano F, Mampaso F, Garcia Martin F, Pardo A, Orte L, Teruel JL, Quereda C, Ortuno J (1988) Allograft membranous glomerulonephritis and renal-vein thrombosis in a patient with a lupus anticoagulant factor. Nephrol Dial Transplant 3:684–689

    Google Scholar 

  76. Appan S, Boey ML, Lim KW (1987) Multiple thromboses in systemic lupus erythematosus. Arch Dis Child 62:739–741

    Google Scholar 

  77. Asherson RA, Khamashta MA, Baguley E, Oakley CM, Rowell NR, Hughes GRV (1989) Myocardial infarction and antiphospholipid antibodies in SLE and other disorders. Q J Med 73:1103–1115

    Google Scholar 

  78. Kant KS, Pollak VE, Weiss MA, Glueck HI, Miller AN, Hess EV (1982) Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine 60:71–86

    Google Scholar 

  79. Leaker B, Fairley KF, Dowling J, Kincaid-Smith P (1987) Lupus nephritis: clinical and pathological correlation. Q J Med 62: 163–179

    Google Scholar 

  80. Ponticelli C, Imbasciati E, Brancaccio D, Tarantino A, Rivolta E (1974) Acute renal failure in systemic lupus erythematosus. Br Med J 3:716–719

    Google Scholar 

  81. Kincaid-Smith P, Fairley KF, Kloss M (1988) Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure. Q J Med 69:795–815

    Google Scholar 

  82. Gelfand J, Truong L, Stern L, Pirani CL, Appel GB (1985) Thrombotic thrombocytopenic purpura syndrome in systemic lupus erythematosus: treatment with plasma infusion. Am J Kidney Dis 6: 154–160

    Google Scholar 

  83. Kincaid-Smith P, Nicholls K (1990) Renal thrombotic microvascular disease associated with lupus anticoagulant. Nephron 54:255–258

    Google Scholar 

  84. Derksen AHWM, Biemsma D, Bouma BN, Gmelig Meyling FHJ, Kater L (1986) Discordant effect of prednisone on anticardiolipin antibodies and the lupus anticoagulant. Arthritis Rheum 29: 1295–1296

    Google Scholar 

  85. Walport MJ (1989) Pregnancy and antibodies to phospholipids. Ann Rheum Dis 48:795–797

    Google Scholar 

  86. Lubbe WF, Liggins GC (1985) Lupus anticoagulant and pregnancy. Am J Obstet Gynecol 153:322–327

    Google Scholar 

  87. Loizou S, Byron M, Englert HJ, David J, Hughes GRV, Walport MJ (1988) Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus. Q J Med 68:525–531

    Google Scholar 

  88. Unander AM, Norberg R, Hahn L, Arfors L (1987) Anticardiolipin antibodies and complement in ninety nine women with habitual abortion. Am J Obstet Gynecol 156:114–119

    Google Scholar 

  89. Branch DW, Scott JR, Kochenour NK, Herschgold E (1985) Obstetric complications associated with the lupus anticoagulant. N Engl J Med 313:1322–1326

    Google Scholar 

  90. Lockshin MD, Qamar T, Druzin ML, Goei S (1987) Antibody to cardiolipin, lupus anticoagulant, and fetal death. J Rheumatol 14: 259–262

    Google Scholar 

  91. Abramowsky CR, Vegas ME, Swinehart G, Byves MT (1980) Decidual vasculopathy of the placenta in lupus erythematosus. N Engl J Med 303:668–672

    Google Scholar 

  92. Cowchock S, Smith JB, Gocial B (1986) Antibodies to phospholipids and nuclear antigens in patients with repeated abortions. Am J Obstet Gynecol 155:1002–1010

    Google Scholar 

  93. Simel DL, StClair EW, Adams J, Greenberg CS (1987) Correction of hypoprothrombinemia by immunosuppressive treatment of the lupus anticoagulant-hypoprothrombinemia syndrome. Am J Med 83:563–566

    Google Scholar 

  94. Harris EN, Gharavi AE, Hegde U, Derue G, Morgan SH, Englert H, Chan JKH, Asherson RA, Hughes GRV (1985) Anticardiolipin antibodies in autoimmune thrombocytopenia. Br J Haematol 59: 231–234

    Google Scholar 

  95. Weinstein C, Miller MH, Axtens R, Buchanan R, Littlejohn O (1987) Livedo reticularis associated with increased titers of anticardiolipin antibody in systemic lupus erythematosus. Arch Dermatol 123:596–600

    Google Scholar 

  96. Englert HJ, Loizou S, Derue G, Walport M, Hughes GRV (1989) Clinical and immunologic features of livedo reticularis in lupus: a case control study. Am J Med 87:408–410

    Google Scholar 

  97. Bouchez B, Arnott G, Hatron PY, Wattel A, Devulder B (1985) Chorea and systemic lupus with circulating anticoagulant. Rev Neurol (Paris) 141:571–577

    Google Scholar 

  98. Colaco CB, Scadding GK, Lockhart S (1987) Anti cardiolipin antibodies in neurological disorders: cross reaction with anti single stranded DNA activity. Clin Exp Immunol 68:313–319

    Google Scholar 

  99. Harris EN, Gharavi AE, Mackworth Young CG, Patel BM, Derue G, Hughes GRV (1985) Lupoid sclerosis: a possible pathogenetic role for antiphospholipid antibodies. Ann Rheum Dis 44:281–283

    Google Scholar 

  100. Frampton G, Winer JB, Cameron JS, Hughes RAC (1988) Severe Guillain-Barré syndrome: an association with IgA anti-cardiolipin antibody in a series of 92 patients. J Neuroimmunol 19:133–139

    Google Scholar 

  101. Vaarala O Palosuo T, Klemola M, Aho K (1986) Anticardiolipin response in acute infections. Clin Immunol Immunopathol 41: 8–15

    Google Scholar 

  102. Pankewycz OG, Migliorini P, Madaio MP (1987) Polyreactive autoantibodies are nephritogenic in murine lupus nephritis. J Immunol 139: 3287–3294

    Google Scholar 

  103. Mackworth-Young CG, Harris EN, Steere AC, Rizvi F, Malawista SE, Hughes GRV, Gharavi AE (1988) Anticardiolipin antibodies in Lyme disease. Arthritis Rheum 31: 1052–1056

    Google Scholar 

  104. Wilson WA, Perez MC, Michalski JP, Armatis PE (1987) Cardiolipin antibodies and null alleles of C4 in black Americans with systemic lupus erythematosus. J Rheumatol 15: 1768–1772

    Google Scholar 

  105. Inoue K, Nojima S (1969) Immunochemical studies of phospholipids IV. The reactivities of antisera against natural cardiolipin and synthetic cardiolipin-containing antigens. Chem Phys Lipids 3: 70–77

    Google Scholar 

  106. Harris EN, Gharavi AE, Tincani A, Chan JKH, Englert H, Mantelli P, Allegro F, Ballestrieri (sic) G, Hughes GRV (1985) Affinity purified anti cardiolipin and anti DNA antibodies. J Clin Lab Immunol 17: 155–162

    Google Scholar 

  107. Violi F, Valesini G, Ferro D, Tincani A, Balestrieri G, Balsano F (1986) Anticoagulant activity of anticardiolipin antibody. Thromb Res 44: 543–547

    Google Scholar 

  108. Pengo V, Thiagarajan P, Shapiro SS, Heine MJ (1987) Immunological specificity and mechanism of action of IgG lupus anticoagulants. Blood 70: 69–76

    Google Scholar 

  109. McNeil HP, Chesterman CN, Krilis SA (1988) Binding specificity of lupus anticoagulants and anticardiolipin antibodies. Thromb Res 52: 609–619

    Google Scholar 

  110. Frampton G, Cameron JS (1988) Purified anti-phospholipid antibodies (APA) from lupus nephritis patients enhance thromboxane (TxB2) production by activated platelets (abstract). Kidney Int 33: 328

    Google Scholar 

  111. Guarnieri M, Eisner D (1974) A DNA antigen that reacts with antisera to cardiolipin. Biochim Biophys Acta 58: 347–353

    Google Scholar 

  112. Staub HL, Harris EN, Khamashta MA, Savidge G, Chahade WH, Hughes GR (1989) Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant. Ann Rheum Dis 48: 166–169

    Google Scholar 

  113. Lafer EM, Rauch J, Andrzejewski C Jr, Mudd D, Furie B, Furie B, Schwartz RS, Stollar B (1981) Polyspecific monoclonal lupus antibodies reactive with both polynucleotides and phospholipids. J Exp Med 153: 897–909

    Google Scholar 

  114. Koike T, Maruyama N, Funaki H, Tumioka H, Yoshida S (1984) Specificity of mouse hydridoma antibodies to DNA. II. Phospholipid reactivity and biological false-positive serological test for syphilis. Clin Exp Immunol 57: 347–350

    Google Scholar 

  115. Schoenfeld Y, Rauch J, Massicotte H, Datta S, André-Schwartz J, Stollar BD, Schwartz RS (1983) Polyspecificity of monoclonal lupus autoantibodies produced by human-human hydridomas. N Engl J Med 308: 414–420

    Google Scholar 

  116. Rauch J, Tannenbaum H, Stollar BD, Schwartz RS (1984) Monoclonal anticardiolipin antibodies bind to DNA. Eur J Immunol 14: 529–534

    Google Scholar 

  117. Carroll P, Stafford D, Schwartz RS, Stollar BD (1985) Murine monoclonal anti-DNA autoantibodies bind to endogenous bacteria. J Immunol 135: 1086–1090

    Google Scholar 

  118. Harris EN, Gharavi AE, Loizou S, Derue G, Chan JK, Patel BM, Mackworth-Young CG, Bunn CC, Hughes GRV (1985) Crossreactivity of antiphospholipid antibodies. J Clin Lab Immunol 16: 1–16

    Google Scholar 

  119. Eilat D, Zlotnick AY, Fischel R (1986) Evaluation of the cross reaction between anti-DNA and anti-cardiolipin antibodies in SLE and experimental animals. Clin Exp Immunol 65: 269–278

    Google Scholar 

  120. Koike T, Tomioka H, Kamagai A (1982) Antibodies cross reactive with DNA and cardiolipin in patients with systemic lupus erythematosus. Clin Exp Immunol 50: 298–302

    Google Scholar 

  121. Colaco CB, Elkon KB (1985) The lupus anticoagulant: a disease marker in antinuclear antibody-negative lupus that is cross reactive with autoantibodies to double stranded DNA. Arthritis Rheum 28: 67–74

    Google Scholar 

  122. Smeenk RJ, Lucassen WAM, Swaak TJG (1987) Is anticardiolipin activity a cross reaction of anti DNA or a separate entity? Arthritis Rheum 30:607–617

    Google Scholar 

  123. McNeil HP, Chesterman CN, Krilis SA (1990) Antiphospholipid antibodies are directed against a complex antigen which includes a lipid-binding glycoprotein (abstract). Clin Exp Rheumatol 8: 209

    Google Scholar 

  124. Galli M, Maasen C, Comfurius P, Hemker HC, Barbui T, Zwaal RFA, Bevers EM (1990) Isolation and characterisation of a plasmatic factor interacting with anticardiolipin antibodies (abstract). Clin Exp Rheumatol 8: 206

    Google Scholar 

  125. Yin ET, Gaston LW (1965) Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus. Thromb Diath Haemorr 14: 88–115

    Google Scholar 

  126. Rivard GE, Schiffman S, Rapaport SI (1974) Cofactor of the “lupus anticoagulant”. Thromb Diath Haemorr 32: 554–563

    Google Scholar 

  127. Firkin BG, Booth P, Hendrix L, Howard MA (1978) Demonstration of a platelet bypass mechanism in the clotting system using an acquired anticoagulant. Am J Hematol 5: 81–92

    Google Scholar 

  128. Schick PK, Kurica KB, Chacko GK (1976) Location of phosphatidylethanolamine and phosphatidylserine in the human platelet plasma membrane. J Clin Invest 57: 1221–1226

    Google Scholar 

  129. Howard MA, Firkin BG (1983) Investigations of the lupus-like inhibitor bypassing activity of platelets. Thromb Haemost 50: 775–779

    Google Scholar 

  130. Hasselaar P, Derksen RHMW, Blokzijl L, Groot PG de (1988) Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesis. Thromb Haemost 59: 80–85

    Google Scholar 

  131. Khamashta MA, Harris EA, Gharavi AE Derue G, Gil A, Vasquez JJ, Hughes GRV (1988) Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis 47: 849–854

    Google Scholar 

  132. Parbtani A, Frampton G, Cameron JS (1980) Platelet and plasma serotonin concentrations in glomerulonephritis. Clin Nephrol 14: 112–123

    Google Scholar 

  133. Marchesi D, Parbtani A, Frampton G, Livio M, Remuzzi G, Cameron JS (1981) Thrombotic tendency in systemic lupus erythematosus (letter). Lancet I: 719

    Google Scholar 

  134. Frampton G, Perl S, Bennett A Cameron JS (1986) Platelet associated DNA and anti-DNA antibody in systemic lupus erythematosus with nephritis. Clin Exp Immunol 63: 621–628

    Google Scholar 

  135. Frampton G, Gharavi A, Harris EN, Hughes GRV, Cameron JS (1984) Platelet associated DNA, anti DNA antibody and anticardiolipin antibody in lupus nephritis (abstract). Eur J Rheumatol Inflamm 7: 19–20

    Google Scholar 

  136. Le Roux G, Wautier MP, Guillevin L, Wautier JL (1986) IgG binding to endothelial cells in systemic lupus erythematosus. Thromb Haemost 56: 144–146

    Google Scholar 

  137. Vismara A, Meroni PL, Tincani A, Harris EN, Barcellini W, Brucato A, Khamashta M, Hughes GRV, Zanussi C, Balestrieri G (1988) Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol 74: 247–253

    Google Scholar 

  138. Carreras LO, Vermylen JG (1982) ‘Lupus’ anticoagulant and thrombosis: possible role of inhibition of prostacyclin formation. Thromb Haemost 48: 28–40

    Google Scholar 

  139. McVerry BA, Machin SJ, Parry H, Goldstone AH (1980) Reduced prostacyclin activity in systemic lupus erythematosus. Ann Rheum Dis 39: 524–525

    Google Scholar 

  140. Rustin MHA, Bull HA, Dowd PM, Isenberg DA, Snaith ML, Machin SL (1987) Presence of the lupus anticoagulant in patients with systemic lupus erythematosus does not cause inhibition of prostacyclin production (abstract). Thromb Haemost 58: 390

    Google Scholar 

  141. Petraiuolo W, Bocill E, Hoak J (1987) The lupus anticoagulant does not inhibit the release of prostacyclin from human endothelial cells (abstract). Thromb Haemost 58: 390

    Google Scholar 

  142. Violi F, Valesini G, Iulano L, Ghiselli A, Falco M, Balsano F (1987) Anticardiolipin antibodies and prostacyclin synthesis (letter). Thromb Haemost 57: 374

    Google Scholar 

  143. Coade SB, Haaren E van, Loizou S, Walport MJ, Denman AM, Pearson JD (1989) Endothelial prostacyclin release in systemic lupus erythematosus. Thromb Haemost 61: 97–100.

    Google Scholar 

  144. Comp PC, De Bault LE, Esmon NL, Esmon CT (1983) Human thrombomodulin is inhibited by IgG from two patients with nonspecific anticoagulants (abstract). Blood 62 [Suppl 1]: 299 a

    Google Scholar 

  145. Freyssinet J-M, Cazenave J-P (1987) Lupus like anticoagulants: modulation of the protein C pathway and thrombosis. Thromb Haemost 58: 679–681

    Google Scholar 

  146. Cariou R, Tobelem G, Soria C, Caen J (1986) Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant (letter). N Engl J Med 314: 1193–1194

    Google Scholar 

  147. Van Hinsberg VWM, Bertina, RM, Wijngaarden A van, Tilburg NH van, Emels JJ, Haverkate F (1985) Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood 65: 444–451

    Google Scholar 

  148. Sakata Y, Curriden S, Lawrence D, Griffin JH, Loskutoff DJ (1985) Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity. Proc Natl Acad Sci USA 82: 1121–1125

    Google Scholar 

  149. Angles-Cano E, Sultan Y, Clauvel J-P (1979) Predisposing factors to thrombosis in systemic lupus erythematosus. Possible relation to endothelial cell damage. J Lab Clin Med 94: 312–322

    Google Scholar 

  150. Byron MA, Allington MJ, Chapel HM, Mowat AG, Cederholm-Williams SA (1987) Indications of vascular endothelial dysfunction in systemic lupus erythematosus. Ann Rheum Dis 46: 741–745

    Google Scholar 

  151. Cosgriff TM, Martin BA (1981) Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis. Arthritis Rheum 24: 94–96

    Google Scholar 

  152. Sanfelippo MJ, Drayna CJ (1982) Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis. Am J Clin Pathol 77: 275–279

    Google Scholar 

  153. De Wolf F, Carreras LO, Moerman P, Vermylen J, Assche A van, Renaer M (1982) Decidual vasculopathy and extensive placental infarction in a patient with thromboembolic recurrent fetal loss and a lupus anticoagulant. Am J Obstet Gynecol 142: 829–834

    Google Scholar 

  154. Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN (1985) Measurement of anticardiolipin by an enzyme linked immunoabsorbent assay (ELISA) standardization and quantitation of results. Clin Exp Immunol 54: 709–712

    Google Scholar 

  155. Colaco CB, Male DK (1985) Anti-phospholipid antibodies in syphilis and a thrombotic subset of SLE: distinct profiles of epitope specificity. Clin Exp Immunol 59: 449–456

    Google Scholar 

  156. Mouritsen S Hoeier-Madsen M, Wiil A, Orum O, Strandberg Petersen N (1989) The specificity of anti-cardiolipin antibodies from syphilis patients and from patients with systemic lupus erythematosus. Clin Exp Immunol 76: 178–183

    Google Scholar 

  157. Cowchock S, Fort J, Munoz S, Norberg R, Maddrey W (1988) False positive ELISA tests for cardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abortion. Clin Exp Immunol 73: 289–294

    Google Scholar 

  158. Harris EN, Gharavi AE, Patel SP, Hughes GR (1987) Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 215–222

  159. Third International symposium on anti-phospholipid antibodies, Kingston Jamaica, January 5–8 1988. Clin Exp Rheumatol 6: 189–215

  160. Triplett DA (1989) Screening for the lupus anticoagulant. Res Clin Lab 19: 379–389

    Google Scholar 

  161. Byron MA (1982) The clotting defect in SLE. Clin Rheum Dis 8: 137–151

    Google Scholar 

  162. Triplett DA, Brandt JT, Musgrave KA, Orr CA (1985) The laboratory heterogeneity of lupus anticoagulants. Arch Pathol Lab Med 109: 946–951

    Google Scholar 

  163. Alving BM, Barr CF, Tang DB (1990) Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times. Am J Med 88: 112–116

    Google Scholar 

  164. Triplett DA, Brandt JT, Musgrave KA, Orr CA (1988) The relationship between lupus anticoagulants and antibodies to phospholipids. JAMA 259: 550–554

    Google Scholar 

  165. Rosove MH, Brewer PMC, Runge A, Hirji K (1989) Simultaneous lupus anticoagulant and anticardiolipin assays and clinical detection of antiphospholipids. Am J Hematol 32: 148–149

    Google Scholar 

  166. Asherson RA, Chan JKH, Harris EN, Gharavi AE, Hughes GRV (1985) Anti cardiolipin antibody, recurrent thrombosis and warfarin withdrawal. Ann Rheum Dis 44:823–825

    Google Scholar 

  167. Schleider MA, Nachman RL, Jaffe EA, Coleman M (1976) A clinical study of the lupus anticoagulant. Blood 48: 499–509

    Google Scholar 

  168. Landi G, Calloni MV, Sabbadini MG (1983) Recurrent ischemic attacks in young adults with lupus anticoagulant. Stroke 14: 377–379

    Google Scholar 

  169. Trudinger BJ, Stewart GJ, Cook CM, Connelly A, Exner T (1988) Monitoring lupus anticoagulant-positive pregnancies with umbilical artery flow velocity waveforms. Obstet Gynecol 72: 215–218

    Google Scholar 

  170. Prentice RL, Gatenby PA, Loblay RH, Shearman RP, Kronenberg H, Basten A (1984) Lupus anticoagulant in pregnancy (letter). Lancet II: 464

    Google Scholar 

  171. Lockshin MD (1987) Anticardiolipin antibody. Arthritis Rheum 30: 471–472

    Google Scholar 

  172. Elder MG, Swiet M de, Robertson A, Elder MA, Flloyd E, Hawkins DF (1988) Low-dose aspirin in pregnancy (letter). Lancet I: 410

    Google Scholar 

  173. Ordi J, Barquinero J, Vilardell M, Jordana R, Tolosa C, Selva A, Genover E (1989) Fetal loss treatment in patients with antiphospholipid antibodies. Ann Rheum Dis 48: 798–802

    Google Scholar 

  174. Rosove MH, Tabsh K, Howard P, Wasserstrum N, Bronkman CR, Hahan BH, Kalunian KC (1987) Heparin therapy for prevention of fetal wastage in women with anticardiolipin antibodies and lupus anticoagulants (abstract). Blood 70 [Suppl 5]: 379a

    Google Scholar 

  175. Englert HJ, Derue GM, Loizou S, Hawkins DF, Elder MG, Swiet M de, Walport MJ, Hughes GRV (1988) Pregnancy and lupus: prognostic indicators and response to treatment. Q J Med 66: 125–136

    Google Scholar 

  176. Scott JR, Branch DW, Kochenour NK, Ward K (1988) Intravenous globulin treatment of pregnant patients with recurrent pregnancy loss due to antiphospholipid antibodies and Rh immunisation. Am J Obstet Gynecol 159: 1055–1056

    Google Scholar 

  177. Carreras LO, Perez GN, Vega HR, Casavilla F (1988) Lupus anticoagulant and recurrent fetal loss successful treatment with gammaglobulin. Lancet II: 393–394

    Google Scholar 

  178. Frampton G, Cameron JS, Thom M, Jones S, Raftery M (1987) Successful removal of anti-phospholipid antibody during pregnancy using plasma exchange and low dose prednisolone (letter). Lancet II: 1023–1024

    Google Scholar 

  179. Fulcher D, Stewart G, Exner T, Trudinger B, Jeremy R (1989) Plasma exchange and the anticardiolipin syndrome in pregnancy (letter). Lancet II: 171

    Google Scholar 

  180. Harris EN (1988) Solid phase anti-cardiolipin test revisited. Am J Med 85: 599–600

    Google Scholar 

  181. Mackworth-Young CG, Loizou S, Walport MJ (1989) Antiphospholipid antibodies and disease. Q J Med 72: 767–777

    Google Scholar 

  182. Mackworth Young C (1989) Antiphospholipid antibodies: more than just a disease marker? Immunol Today 11: 60–65

    Google Scholar 

  183. Lie JT (1989) Vaculopathy in the antiphospholipid syndrome: thrombosis of vasculitis, or both? J Rheumatol 16: 713–715

    Google Scholar 

  184. Simon LS, Gorn AH (1990) Case no 11-1990. Case records of the Massachusetts General Hospital. N Engl J Med 322: 754–769

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Renal Unit, Clinical Science Laboratories, Guy's Hospital, 17th Floor Guy's Tower, SE1 9RT, London, UK

    J. Stewart Cameron & G. Frampton

Authors
  1. J. Stewart Cameron
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Frampton
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cameron, J.S., Frampton, G. The ‘antiphospholipid syndrome’ and the ‘lupus anticoagulant’. Pediatr Nephrol 4, 663–678 (1990). https://doi.org/10.1007/BF00858647

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00858647

Key words

Search

Navigation